GASTRIC CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s Stomach Cancer News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

September 18, 2017

Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

By Anonymous User anonymous_user_10987

Keytruda (pembrolizumab) appears promising in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid.1 Stomach cancer (gastric cancer), is the third leading cause of cancer-related deaths worldwide. Overall, the 5-year survival rate for patients with gastric cancer […]

View full entry

Tags: Gastric Cancer, immunotherapy, KEYNOTE-059 programmed death-ligand 1, keytruda, metastatic gastric cancer, News Tips and Features, News Tips and Features Other, PD-L1, pembrolizumab, Precision Cancer Medicine, stomach cancer


Opdivo® Improves Survival in Advanced Stomach Cancer

November 22, 2016

Opdivo® Improves Survival in Advanced Stomach Cancer

By megm megm

The immune-stimulating agent Opdivo® (nivolumab) appears to significantly improve overall survival among patients with advanced stomach cancer for which no standard treatment options exist. Opdivo is not yet approved for stomach cancer. Stomach cancer (gastric cancer), is the third leading cause of cancer-related deaths worldwide. Overall, the 5-year survival rate for patients with gastric cancer […]

View full entry

Tags: Gastric Cancer, News Tips and Features, News Tips and Features Other, nivolumab, Opdivo, stomach cancer


Novel Antibody Improves Survival in Advanced Stomach Cancer

June 28, 2016

Novel Antibody Improves Survival in Advanced Stomach Cancer

By Anonymous User anonymous_user_10987

The novel agent, IMAB362, which stimulates the immune system to attack a certain protein expressed by many stomach cancer cells, has demonstrated a significant improvement in survival compared to standard therapy among patients with this disease. These results were presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO). Stomach cancer, […]

View full entry

Tags: 2016, advanced, asco, Gastric Cancer, GEJ cancer, IMAB362, News Tips and Features, News Tips and Features Other, Stages III-IV Gastric Cancer, stomach cancer


Gastric Cancer Risk Factors You Need to Know

February 8, 2016

Gastric Cancer Risk Factors You Need to Know

By Anonymous User anonymous_user_10987

Successful treatment for stomach or gastric cancer starts with early detection. Most cases of stomach cancer are diagnosed in the advanced stages as there is no routine test for early detection. This makes it very important for people to know their risk for developing stomach cancer. The main risk factors for gastric cancer include: Gender: […]

View full entry

Tags: endoscopy screening, Gastric Cancer, News Tips and Features, News Tips and Features Other, risk factors, Screening/Prevention Gastric Cancer, stomach cancer, symptoms


View more articles like this
More news and in-depth Gastric Cancer information

CONDITIONS OF THE GI TRACT